Nebenwirkungen · Ebvallo
Ebvallo 2.8 × 107 – 7.3 × 107 cells/mL dispersion for injection · Abschnitt 4.8 · PDF-Seite 8–9
HOS-139991 · Präparat HOS-098428
8 System organ class (SOC) Adverse reaction Frequency Chest paind Common Pain Common Localised oedema Common General physical health deterioration Common Investigations Neutrophil count decreased Very common White blood cell count decreased Very common Aspartate aminotransferase increased Very common Alanine aminotransferase increased Very common Blood alkaline phosphatase increased Very common Lymphocyte count decreased Common Blood creatinine increased Common Blood lactate dehydrogenase increased Common Platelet count decreased Common Blood fibrinogen decreased Common Injury, poisoning and procedural Post procedural oedema Common complications a Graft-versus-host disease (GvHD) includes GvHD in gastrointestinal tract, GvHD in liver, rash maculo-papular (skin GvHD) b Abdominal pain includes abdominal pain, abdominal discomfort, abdominal pain lower c Rash includes rash, rash erythematous, rash maculo-papular, rash pustular d Chest pain includes musculoskeletal chest pain, non-cardiac chest pain
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-02T09:37:00Z · SHA-256 b6b70030408178a0a00d53670d3028d050f247217c320de44f31caafbd3ecd0c · Passage 3a491c7b41fbdae3246b392323c2e1db35c090e2813c4d222f429b8c2feb1185 · Zeichen 6552–8586 im Abschnitt